25 February 2026
Malaghan ambassador, trustee and living proof of the power of CAR T-cell therapy, David Downs, explores CAR T-cell therapy. He answers some of the common questions Kiwis are asking about this ground-breaking treatment and the Malaghan's efforts to bring it to New Zealand.
Part 1: What is CAR T-cell therapy
Part 2: The Malaghan's ground-breaking trials
Part 3: Breaking ground with clinical trials in New Zealand
Part 4: Why does the Malaghan have to fundraise for CAR-T?
Part 5: Scaling new therapies through commercialisation
Support bringing CAR T-cell therapy to Aotearoa New Zealand
Join us in making CAR T-cell therapy accessible and affordable for all New Zealanders in need.
To learn more about how you can join this ground-breaking effort please contact the Malaghan Institute's philanthropy manager An-Li Theron.
Or, if you're keen to support our efforts in other ways, contact the Malaghan Institute's communications team.
Related articles
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
What's next for CAR T-cell therapy
27 May 2026
Researchers explore 'RENTAL CAR' approach to CAR T-cell therapy
21 May 2026